Yingtai Medical (01501): Wang Ruiqin resigns as non-executive director of the company

Zhitong Finance App News, Yingtai Healthcare (01501) issued an announcement. Mr. Wang Ruiqin has proposed to resign as a non-executive director of the company due to adjustments in his personal work schedule, effective from August 24, 2026 (that is, the date the company received the notice of resignation).

Mr. Jian Xigao and Mr. Xu Hongqun have been independent non-executive directors of the company since December 8, 2018, and have been working continuously for more than seven years. The company is currently preparing for the initial public offering of RMB common stock (A shares) and listing. According to the “Administrative Measures on Independent Directors of Listed Companies” and other A-share related laws and regulations, independent non-executive directors may not serve continuously for more than six years. Since the continuous tenure of Mr. Jian Xigao and Mr. Xu Hongqun has exceeded the upper limit of the A-share regulatory requirements described above, in order to meet the compliance requirements for the A-share listing and to take into account the adjustments to their personal work arrangements, Mr. Ji Xigao and Mr. Xu Hongqun applied to resign as independent non-executive directors of the company and relevant positions in the special committee of the board of directors. The resignations of Mr. Jian Xigao and Mr. Xu Hongqun will take effect from the date the new independent non-executive directors are formally appointed.

After considering the recommendations of the Nomination Committee, the Board of Directors has resolved to recommend the appointment of Dr. Zhang Peng and Dr. Li Yunlong as independent non-executive director candidates for the fourth term of the Board of Directors. The proposed appointment of an independent non-executive director is subject to approval by shareholders by means of an ordinary resolution at the Extraordinary Shareholders' Meeting, and will take effect from the date of approval by the Extraordinary Shareholders' Meeting.

According to the provisions of the company's articles of association, the company held the 2nd 11th Staff Congress on August 24, 2026 to elect Ms. Chen Jie as the representative director of the 4th board of directors. She will form the 4th board of directors with other directors. The term of office will begin on the date of Ms. Chen Jie's election and end on the date the term of the fourth board of directors expires.